Gabapentin Tablet
Product Images NDC 72789-217

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72789-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789217 Label (72789217)

This is a warning label for Gabapentin tablets, which may cause drowsiness and impair driving. Alcohol should be avoided while taking these tablets, and they should not be taken simultaneously with antacids. The label cautions to keep the tablets out of reach of children and to consult a doctor in case of side effects. Dosage and storage details can be found in the package insert. Each film-coated tablet contains 800mg of Gabapentin USP, and the bottle contains 60 tablets with an expiration date of 07/2023. There are also manufacturing details and a GTIN and SNO number. No organoleptic markings are visible in the text.*

FDA Label Image

Figure 1 (Image 01)

This is a chart showing the mean pain score for a study that compares the effectiveness of two types of treatment for pain: "Parkod" (either titrated or administered at a fixed dose), and gabapentin (at a dose of 3600 mg/day), compared to a placebo. The study spanned a total of several weeks, with the baseline measurement taken at the start.*

FDA Label Image

Figure 2 (Image 02)

This is a graphical representation of a clinical trial study evaluating the effect of gabapentin at a daily dose of either 1800mg or 2400mg on pain. The study included a 4-week period where participants received a fixed dose of the drug, followed by a 3-week dose titration period. A placebo was also used as a control. The mean pain score was measured weekly and plotted on the graph.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.